Phone
Address Talkabouturology, Russia, Nizhny Novgorod
Skype ukitcom
Email Talkabouturology@list.ru
  Talk about urology
<span style="font-weight: bold;">Surgical Management of BPH</span>&nbsp;
Surgical Management of BPH 
The Surgical Management of BPH (2021) is an exciting new educational initiative featuring a series of four interactive, case-based, live virtual courses conducted in English, Spanish, Portuguese, and French. For each session, a Moderator will engage two other subject matter experts in an interactive, interview-style presentation and discussion. Semi-live surgical videos will be utilized to demonstrate and emphasize the significant elements of various BPH procedures. 
<span style="font-weight: bold;">Advanced Practice Provider Core Curriculum: Clinically Insignificant Stone Fragments (2020)&nbsp;</span>
Advanced Practice Provider Core Curriculum: Clinically Insignificant Stone Fragments (2020) 
FREE 
Learning Objectives:

After completion of this activity, participants will be able to: 

Define the classic size criteria of clinically insignificant residual stone fragments and what may be the newer, more relevant size. 

Discuss the risk of a residual kidney stone and the likelihood of outcomes including remaining asymptomatic, growth or needing further intervention. 

<span style="font-weight: bold;">Advanced Practice Provider Core Curriculum: Neuropathic Bladder (2020)&nbsp;</span>
Advanced Practice Provider Core Curriculum: Neuropathic Bladder (2020) 
FREE 

After completion of this activity, participants will be able to: 

Evaluate and characterize patients presenting with neurogenic bladder in a clinical setting. 

Interpret basic urodynamic tracing of a patient with neurogenic bladder. 

Counsel patients regarding the risks and benefits of the treatments for various types of neurogenic bladder. 

<span style="font-weight: bold;">Adjuvant Treatment in Bladder Cancer Podcast (2021)&nbsp;</span>
Adjuvant Treatment in Bladder Cancer Podcast (2021) 
FREE 
At the conclusion of this activity, participants will be able to: 

Discuss the evolving landscape of adjuvant therapy for the treatment of advanced bladder cancer and analyze the risks and benefits of the new and emerging treatment options. 

Describe the mechanism of action and associated side effects of the new adjuvant therapy. 

Differentiate the roles between the urologist and medical oncologist in the care of patients with bladder cancer. 

Discuss the opportunities for the coordination of care between the urologists and medical oncologists. 

<span style="font-weight: bold;">Female Incontinence (2020)&nbsp;</span>
Female Incontinence (2020) 
FREE 

After completion of this activity, participants will be able to: 

Identify basic female pelvic anatomy. 

Apply the skills required for history taking in incontinent female patients. 

Describe the differences between stress urinary incontinence and urgency urinary incontinence. 

Describe the treatments available for stress and urgency urinary incontinence. 

<span style="font-weight: bold;">Benign Prostatic Hyperplasia (2020)&nbsp;</span>
Benign Prostatic Hyperplasia (2020) 
FREE 
After completing this activity, the participant will be able to: 

Describe the pathophysiology of lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH). 

Identify and implement the necessary diagnostic evaluation of the patient with BPH. 

Describe indications and the evidence supporting the use of medical and surgical management options in the patient with BPH. 

<span style="font-weight: bold;">Hematuria and Microhematuria (2020)&nbsp;</span>
Hematuria and Microhematuria (2020) 
Price: FREE 
After completion of this activity, participants will be able to: 

Apply the AUA Guidelines regarding the evaluation of patients with possible hematuria in a safe and effective manner and with appropriate resource allocation. 

Counsel patients with hematuria about possible etiologies and their significance. 

<span style="font-weight: bold;">Hypogonadism (2020)&nbsp;</span>
Hypogonadism (2020) 
FREE 
After completion of this activity, participants will be able to: 

Describe the physiologic roles of testosterone and the symptoms of low testosterone. 

Identify the health benefits of testosterone replacement therapy (TRT). 

State the controversies and risks of TRT. 

Describe the options for TRT and how patients should be monitored. 

<span style="font-weight: bold;">Kidney Stones &amp; Dietary Considerations (2020)&nbsp;</span>
Kidney Stones & Dietary Considerations (2020) 
FREE 
After completion of this activity, participants will be able to: 

Identify several risk factors that contribute to kidney stone development. 

Prescribe appropriate labs, testing and imaging as suggested by AUA Guidelines for medical management of kidney stones. 

Identify a few kidney stone dietary risk factors. 

Prescribe appropriate interventions for hypercalciuric, hypocitraturic, hyperoxaluric or hyperuricosuric patients. 

Describe general dietary/lifestyle tips regarding kidney stone prevention. 

<span style="font-weight: bold;">Medical &amp; Surgical Treatment of Erectile Dysfunction (2020)&nbsp;</span>
Medical & Surgical Treatment of Erectile Dysfunction (2020) 
FREE 
After completion of this activity, participants will be able to: 

Recognize the pathophysiology of erectile dysfunction. 

Describe risk factors for erectile dysfunction. 

Perform comprehensive workup of an erectile dysfunction patient. 

Identify hypogonadism and treatment options when appropriate. 

Facilitate a comprehensive discussion with the patient on erectile dysfunction treatment options and engage in shared decision-making. 

<span style="font-weight: bold;">Neuropathic Bladder (2020)</span>&nbsp;
Neuropathic Bladder (2020) 
FREE 
After completion of this activity, participants will be able to: 

 Evaluate and characterize patients presenting with neurogenic bladder in a clinical setting. 

Interpret basic urodynamic tracing of a patient with neurogenic bladder. 

Counsel patients regarding the risks and benefits of the treatments for various types of neurogenic bladder. 

<span style="font-weight: bold;">OAB Syndrome – Evaluation &amp; Management (2020)</span>&nbsp;
OAB Syndrome – Evaluation & Management (2020) 
FREE 
After completion of this activity, participants will be able to: 

Implement OAB treatment based on the AUA Guidelines. 

Recognize the third line more invasive treatments for OAB and at what point it is appropriate to offer them. 

<span style="font-weight: bold;">Penile Anomalies (2020)&nbsp;</span>
Penile Anomalies (2020) 
FREE 
After completion of this activity, participants will be able to: 

Describe normal penile anatomy. 

Recognize common penile anomalies to aid in the management of genitourinary tract conditions. 

Distinguish potentially malignant lesions from benign conditions. 

Distinguish penile anomalies that warrant acute intervention from other anomalies. 

<span style="font-weight: bold;">Recurrent UTI (2020)</span>&nbsp;
Recurrent UTI (2020) 
FREE 
After completion of this activity, participants will be able to: 

Outline definitions and risk factors for recurrent UTIs 

Review guidelines for evaluation and treatment of uncomplicated recurrent UTIs 

Diagnose and treat uncomplicated UTIs 

Diagnose and treat catheter associated UTIs (CA-UTI) 

Describe the available antibiotic and non-microbial prophylaxis strategies 

<span style="font-weight: bold;">Screening Smarter for Prostate Cancer (2020)&nbsp;</span>
Screening Smarter for Prostate Cancer (2020) 
FREE 
After completion of this activity, participants will be able to: 

Describe the benefits and limitations of screening for prostate cancer. 

Identify the use of newer biomarkers to improve the screening paradigm. 

<span style="font-weight: bold;">STD's and Prostatitis (2020)&nbsp;</span>
STD's and Prostatitis (2020) 
FREE 
After completion of this activity, participants will be able to: 

Classify STD's according to clinical presentation. 

Utilize the appropriate diagnostic tests based on clinical presentation in regards to STD's. 

Identify the guideline approved antibiotics for each STD. 

Describe the current classification system for prostatitis syndromes. 

Diagnose patients suffering from prostatitis based on clinical presentation. 

Utilize the UPOINT system to classify and treat men with chronic pelvic pain. 

<span style="font-weight: bold;">Testicular Neoplasm (2020)&nbsp;</span>
Testicular Neoplasm (2020) 
FREE 
After completion of this activity, participants will be able to: 

Describe and understand the epidemiology and pathophysiology of testicular cancer. 

Demonstrate the proper evaluation and work-up for a testicular neoplasm. 

Describe the medical and surgical management options for testicular cancer. 

<span style="font-weight: bold;">Urodynamics Basics (2020)&nbsp;</span>
Urodynamics Basics (2020) 
FREE 
After completion of this activity, participants will be able to: 

Discuss the indications for and rationale behind urodynamics (UDS). 

Describe the basics of UDS and its terminology. 

<span style="font-weight: bold;">Urological Emergencies (2020)&nbsp;</span>
Urological Emergencies (2020) 
FREE 
After completion of this activity, participants will be able to: 

Identify common and uncommon kidney and bladder emergencies that may be seen in an ambulatory setting. 

Identify penile and scrotal emergencies that may be seen in an ambulatory setting. 

<span style="font-weight: bold;">Advanced Prostate Cancer:&nbsp;AUA/ASTRO/SUO Guideline Podcast: Part 1 (2020)</span>&nbsp;
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline Podcast: Part 1 (2020) 
FREE 
At the conclusion of this activity, participants will be able to: 

Analyze breakthrough treatments in the management of advanced and metastatic hormone sensitive prostate cancer (mHSPC) and castration resistant prostate cancer (CRPC). 

Identify the active agents and their mechanism of action in the management of mHSPC, nmCRPC and mCRPC. 

Describe the indications, sequencing and combinations for treatment with approved agents in the management of mHSPC and nmCRPC.  

<span style="font-weight: bold;">Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline Podcast: Part 2 (2020)&nbsp;</span>
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline Podcast: Part 2 (2020) 
FREE 
At the conclusion of this activity, participants will be able to: 

Review the evidence and outcomes on the treatment of M1 HSPC, MO CRPC and M1 CRPC as outlined in the newly updated AUA Advanced, Metastatic and CRPC guidelines. 

Improve diagnostic and therapeutic decision-making processes by illustrating the application of these guidelines in urological practice. 

<span style="font-weight: bold;">Highlights in Advanced Prostate Cancer (2021)&nbsp;</span>
Highlights in Advanced Prostate Cancer (2021) 
FREE 
At the conclusion of the activity, participants will be able to: 

Describe recent developments in the medical management of advanced prostate cancer. 

Identify the active agents and their mechanism of action in the management of mHSPC, nmCRPC and mCRPC. 

Discuss clinical investigations in the treatment of advanced prostate cancer. 

Analyze the risks and benefits of treatment for advanced prostate cancer. 

Identify the criteria for genetic and genomic testing and utilize the results to improve outcomes among patients with advanced prostate cancer. 

<span style="font-weight: bold;">Highlights in Overactive Bladder (2021)&nbsp;</span>
Highlights in Overactive Bladder (2021) 
FREE 
At the conclusion of the activity, participants will be able to: 

Define the similarities and differences between the various oral pharmacotherapies for OAB and discuss the potential future pharmacological pathways and therapies. 

Realize the importance of setting proper patient expectations regarding treatment of OAB and the potential need for sequential and even additive therapies. 

Discuss optimal use of third line therapies in order to maximize clinical benefit. 

Adeptly counsel patients on the pros and cons and risks and benefits of each of the third line therapies for OAB 

<span style="font-weight: bold;">Annual Review Course Webcast Only (2021)&nbsp;</span>
Annual Review Course Webcast Only (2021) 
FREE 
At the conclusion of this course, participants will be able to: 

Apply basic, generally accepted urological practices for effective, high-quality patient care. 

Demonstrate core knowledge of urology necessary for American Board of Urology (ABU) Qualifying (Part 1) Examination and for the ABU Knowledge Assessment. 

Utilize AUA Guidelines for appropriate patient evaluation and management. 

<span style="font-weight: bold;">AUA 2021 Coding Seminar Webcast (2021)</span>&nbsp;
AUA 2021 Coding Seminar Webcast (2021) 
FREE 
At the conclusion of this webcast, participants will be able to: 

List the changes to Medicare Program for 2021. 

Determine coding for the appropriate level of evaluation and management. 

Code complex urological issues and multiple procedures. 

Describe the relationship between encounter documentation and code selection. 

Describe coding information to be used in the everyday practice. 

<span style="font-weight: bold;">AUA Guidelines on Advanced/Metastatic/Castration Resistant Prostate Cancer Webcast (2021)&nbsp;</span>
AUA Guidelines on Advanced/Metastatic/Castration Resistant Prostate Cancer Webcast (2021) 
FREE 
At the conclusion of this course, participants will be able to: 

Identify the active agents and their mechanism of action in the management of nmCRPC and mCRPC 

Describe sequencing and indications for active treatment with approved agents in the management of nmCRPC 

Analyze the evidence and outcomes on the treatment of MO and M1 CRPC as outlined in the newly updated AUA CRPC guidelines 

Improve diagnostic and therapeutic decision making processes by illustrating the application of these guidelines in urological practice 

Analyze breakthrough treatments in the management of advanced and metastatic hormone naïve prostate cancer 

<span style="font-weight: bold;">AUA Live (2020)</span>&nbsp;
AUA Live (2020) 
FREE 
At the conclusion of the AUA Live program, participants will be able to: 

Describe recent developments in the medical and surgical management of urology patients. 

Identify new technologies for the treatment of urologic conditions. 

Integrate the latest guidelines on the management of urological diseases into their practice. 

<span style="font-weight: bold;">AUA Masterclass Webinar: Erectile Dysfunction (2018)&nbsp;</span>
AUA Masterclass Webinar: Erectile Dysfunction (2018) 
FREE 
Specific topics include: 

Sexual Habits for Men with Erectile Dysfunction 

Second Opinion Caes: 

Erectile Dysfunction (Ask the AUA Guidelines) 

Question & Answer 

<span style="font-weight: bold;">AUA Masterclass Webinar: Incontinence after Prostate Treatment: AUA/SUFU Guideline (2019)</span>&nbsp;
AUA Masterclass Webinar: Incontinence after Prostate Treatment: AUA/SUFU Guideline (2019) 
FREE 
Specific topics include: 

Lecture: Rationale, Patient Population, and Guideline Sections Case Discussions: 

Mild Post-Prostatectomy 

IncontinenceStress Incontinence after Radical Prostatectomy and Adjuvant or Salvage Radiation Therapy 

Incontinence in the Post-TURP patient 

Recurrent incontinence with sling following salvage radiation therapy 

Artificial Urinary Sphincter Failure 

Questions/Answer 

<span style="font-weight: bold;">AUA Research Weekend (2020)</span>&nbsp;
AUA Research Weekend (2020) 
FREE 
Target Audience: 

UrologistsResearch scientists 

Clinical and research faculty 

Clinical and postdoctoral fellows 

ResidentsMedical and graduate students 

Medical professionals employed by industry